Form 4 Tracker
Chris Degnan

Chief Financial Officer · 2 filings · Latest: Oct 8, 2026

UroGen Pharma Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
URGN
Chris DegnanChief Financial OfficerOct 8, 2026
Sale
$36.692,202$80.8K4,561
URGN
Chris DegnanChief Financial OfficerOct 8, 2026
Option Exercise
—4,483—6,763
URGN
Christopher Degnan—Oct 8, 2026
Proposed Sale
$40.702,202$89.6K—